Bellerophon Therapeutics, Inc. (BLPH): Price and Financial Metrics


Bellerophon Therapeutics, Inc. (BLPH): $2.10

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BLPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

BLPH Stock Price Chart Interactive Chart >

Price chart for BLPH

BLPH Price/Volume Stats

Current price $2.10 52-week high $3.50
Prev. close $2.10 52-week low $0.67
Day low $2.06 Volume 35,870
Day high $2.16 Avg. volume 3,629,667
50-day MA $1.40 Dividend yield N/A
200-day MA $1.27 Market Cap 20.04M

Bellerophon Therapeutics, Inc. (BLPH) Company Bio


Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates are INOpulse, a pulsatile nitric oxide delivery device, which is in Phase III clinical trials for the treatment of pulmonary arterial hypertension; and in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases and pulmonary hypertension associated with idiopathic pulmonary fibrosis. Bellerophon Therapeutics, Inc. was founded in 2009 and is founded in Warren, New Jersey.


BLPH Latest News Stream


Event/Time News Detail
Loading, please wait...

BLPH Latest Social Stream


Loading social stream, please wait...

View Full BLPH Social Stream

Latest BLPH News From Around the Web

Below are the latest news stories about BELLEROPHON THERAPEUTICS INC that investors may wish to consider to help them evaluate BLPH as an investment opportunity.

Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

Enrollment concludes earlier than anticipated; pivotal top-line data now expected mid-2023WARREN, N.J., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that the last patient has been enrolled in the ongoing Phase 3 REBUILD study of INOpulse®, a proprietary pulsatile nitric oxide delivery system, for the treatment

Yahoo | January 18, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to start off the day with a breakdown of the biggest pre-market stock movers making the news on Wednesday morning!

William White on InvestorPlace | January 11, 2023

Companies Like Bellerophon Therapeutics (NASDAQ:BLPH) Could Be Quite Risky

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | January 6, 2023

Bellerophon Therapeutics Shares Gained Over 200% Today

Bellerophon Therapeutics Inc (NASDAQ: BLPH) entered into a license agreement for the development and commercialization of INOpulse with Baylor BioSciences. Under the terms of the license agreement, Bellerophon will receive a license payment of $6 million. Additionally, Bellerophon is entitled to royalties of 5% on net sales resulting from all licensed INOpulse indications within Greater China. Baylor BioSciences will receive exclusive rights to develop and commercialize INOpulse within Greater C

Yahoo | January 5, 2023

Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences

Bellerophon to receive a license payment of $6 million, as well as royalties on net sales in Greater ChinaWARREN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that it has entered into a license agreement for the development and commercialization of INOpulse® with Baylor BioSciences, a life sciences compa

Yahoo | January 5, 2023

Read More 'BLPH' Stories Here

BLPH Price Returns

1-mo 149.41%
3-mo 96.26%
6-mo 39.07%
1-year -3.67%
3-year -60.78%
5-year -94.19%
YTD 133.33%
2022 -70.97%
2021 -53.52%
2020 27.16%
2019 -56.29%
2018 -68.99%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8313 seconds.